<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27881780</article-id>
<article-id pub-id-type="pmc">5125247</article-id>
<article-id pub-id-type="publisher-id">0672-16</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.0672-16.2016</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
<subj-group>
<subject>Neurobiology of Disease</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Negative Allosteric Modulation of mGluR5 Partially Corrects Pathophysiology in a Mouse Model of Rett Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tao</surname>
<given-names>Jifang</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0383-9226</contrib-id>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Hao</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coronado</surname>
<given-names>Amanda A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Laittre</surname>
<given-names>Elizabeth</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Osterweil</surname>
<given-names>Emily K.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0582-2284</contrib-id>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yi</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bear</surname>
<given-names>Mark F.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9903-2541</contrib-id>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Picower Institute for Learning and Memory and </aff>
<aff id="aff2"><sup>2</sup>Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, </aff>
<aff id="aff3"><sup>3</sup>Howard Hughes Medical Institute, Boston, Massachusetts 02115, </aff>
<aff id="aff4"><sup>4</sup>Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts 02115, </aff>
<aff id="aff5"><sup>5</sup>Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, and </aff>
<aff id="aff6"><sup>6</sup>Centre for Integrative Physiology, University of Edinburgh, Edinburgh EH8 9XD, United Kingdom</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Mark F. Bear,
<addr-line>Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, 77 Massachusetts Ave., 46-3301, Cambridge, MA 02139.</addr-line><email>mbear@mit.edu</email></corresp>
<fn fn-type="con">
<p>Author contributions: J.T., H.W., E.K.O., and M.F.B. designed research; J.T., H.W., A.A.C., and E.d.L. performed research; Y.Z. contributed unpublished reagents/analytic tools; J.T., H.W., A.A.C., E.d.L., and Y.Z. analyzed data; J.T., H.W., and M.F.B. wrote the paper.</p>
</fn>
<fn fn-type="present-address">
<p>H. Wu's present address: Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>23</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>5</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>36</volume>
<issue>47</issue>
<fpage>11946</fpage>
<lpage>11958</lpage>
<history>
<date date-type="received">
<day>29</day>
<month>2</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>12</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>9</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 the authors 0270-6474/16/3611946-13$15.00/0</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri xlink:href="zns04716011946.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Rett syndrome (RTT) is caused by mutations in the gene encoding methyl-CpG binding protein 2 (MECP2), an epigenetic regulator of mRNA transcription. Here, we report a test of the hypothesis of shared pathophysiology of RTT and fragile X, another monogenic cause of autism and intellectual disability. In fragile X, the loss of the mRNA translational repressor FMRP leads to exaggerated protein synthesis downstream of metabotropic glutamate receptor 5 (mGluR5). We found that mGluR5- and protein-synthesis-dependent synaptic plasticity were similarly altered in area CA1 of <italic>Mecp2</italic> KO mice. CA1 pyramidal cell-type-specific, genome-wide profiling of ribosome-bound mRNAs was performed in wild-type and <italic>Mecp2</italic> KO hippocampal CA1 neurons to reveal the MeCP2-regulated “translatome.” We found significant overlap between ribosome-bound transcripts overexpressed in the <italic>Mecp2</italic> KO and FMRP mRNA targets. These tended to encode long genes that were functionally related to either cytoskeleton organization or the development of neuronal connectivity. In the <italic>Fmr1</italic> KO mouse, chronic treatment with mGluR5-negative allosteric modulators (NAMs) has been shown to ameliorate many mutant phenotypes by correcting excessive protein synthesis. In <italic>Mecp2</italic> KO mice, we found that mGluR5 NAM treatment significantly reduced the level of overexpressed ribosome-associated transcripts, particularly those that were also FMRP targets. Some Rett phenotypes were also ameliorated by treatment, most notably hippocampal cell size and lifespan. Together, these results suggest a potential mechanistic link between MeCP2-mediated transcription regulation and mGluR5/FMRP-mediated protein translation regulation through coregulation of a subset of genes relevant to synaptic functions.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> Altered regulation of synaptic protein synthesis has been hypothesized to contribute to the pathophysiology that underlies multiple forms of intellectual disability and autism spectrum disorder. Here, we show in a mouse model of Rett syndrome (<italic>Mecp2</italic> KO) that metabotropic glutamate receptor 5 (mGluR5)- and protein-synthesis-dependent synaptic plasticity are abnormal in the hippocampus. We found that a subset of ribosome-bound mRNAs was aberrantly upregulated in hippocampal CA1 neurons of <italic>Mecp2</italic> KO mice, that these significantly overlapped with FMRP direct targets and/or SFARI human autism genes, and that chronic treatment of <italic>Mecp2</italic> KO mice with an mGluR5-negative allosteric modulator tunes down upregulated ribosome-bound mRNAs and partially improves mutant mice phenotypes.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>fragile X</kwd>
<kwd>intellectual disability</kwd>
<kwd>metabotropic glutamate receptor</kwd>
<kwd>Rett syndrome</kwd>
<kwd>synaptic protein synthesis</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>